Aphria’s Global Medical Cannabis Supply Chains Aphria has strategically positioned itself in two of the largest cannabis markets outside of Canada, Germany and Israel. These partnerships include collaborating on research initiatives such as clinical trials focused on the use of medical cannabis with leading hospitals and research institutions for global markets internationally. Aphria is doing the same in Latin America, having just added Paraguay to their global medical supply chain, following Argentina and Colombia.